Single-cell analysis reveals the potential mechanisms of pyrotinib resistance in non-small cell lung cancer

相似書籍

• Molecular heterogeneity of anti-PD-1/PD-L1 immunotherapy efficacy is correlated with tumor immune microenvironment in East Asian patients with non-small cell lung cancer
  由: Runsen Jin, et al.
  出版: (2020-08-01)
• The TGFβ-Induced Long Non-coding RNA TBULC Promotes the Invasion and Migration of Non-small Cell Lung Cancer Cells and Indicates Poor Prognosis
  由: Sufei Zheng, et al.
  出版: (2019-12-01)
• PD-L1 expression and smoke exposure as biomarkers for optimizing adjuvant therapy for patients with resected limited-stage small-cell lung carcinoma
  由: Chengming Liu, et al.
  出版: (2023-01-01)
• KRAS‐G12D mutation drives immune suppression and the primary resistance of anti‐PD‐1/PD‐L1 immunotherapy in non‐small cell lung cancer
  由: Chengming Liu, et al.
  出版: (2022-09-01)
• Pyrotinib combined with apatinib for targeting metastatic non-small cell lung cancer with HER2 alterations: a prospective, open-label, single-arm phase 2 study (PATHER2)
  由: Guangjian Yang, et al.
  出版: (2022-08-01)